Literature DB >> 19995808

PhosSNP for systematic analysis of genetic polymorphisms that influence protein phosphorylation.

Jian Ren1, Chunhui Jiang, Xinjiao Gao, Zexian Liu, Zineng Yuan, Changjiang Jin, Longping Wen, Zhaolei Zhang, Yu Xue, Xuebiao Yao.   

Abstract

We are entering the era of personalized genomics as breakthroughs in sequencing technology have made it possible to sequence or genotype an individual person in an efficient and accurate manner. Preliminary results from HapMap and other similar projects have revealed the existence of tremendous genetic variations among world populations and among individuals. It is important to delineate the functional implication of such variations, i.e. whether they affect the stability and biochemical properties of proteins. It is also generally believed that the genetic variation is the main cause for different susceptibility to certain diseases or different response to therapeutic treatments. Understanding genetic variation in the context of human diseases thus holds the promise for "personalized medicine." In this work, we carried out a genome-wide analysis of single nucleotide polymorphisms (SNPs) that could potentially influence protein phosphorylation characteristics in human. Here, we defined a phosphorylation-related SNP (phosSNP) as a non-synonymous SNP (nsSNP) that affects the protein phosphorylation status. Using an in-house developed kinase-specific phosphorylation site predictor (GPS 2.0), we computationally detected that approximately 70% of the reported nsSNPs are potential phosSNPs. More interestingly, approximately 74.6% of these potential phosSNPs might also induce changes in protein kinase types in adjacent phosphorylation sites rather than creating or removing phosphorylation sites directly. Taken together, we proposed that a large proportion of the nsSNPs might affect protein phosphorylation characteristics and play important roles in rewiring biological pathways. Finally, all phosSNPs were integrated into the PhosSNP 1.0 database, which was implemented in JAVA 1.5 (J2SE 5.0). The PhosSNP 1.0 database is freely available for academic researchers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19995808      PMCID: PMC2860229          DOI: 10.1074/mcp.M900273-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  49 in total

1.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites.

Authors:  N Blom; S Gammeltoft; S Brunak
Journal:  J Mol Biol       Date:  1999-12-17       Impact factor: 5.469

2.  BLAT--the BLAST-like alignment tool.

Authors:  W James Kent
Journal:  Genome Res       Date:  2002-04       Impact factor: 9.043

Review 3.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

4.  topoSNP: a topographic database of non-synonymous single nucleotide polymorphisms with and without known disease association.

Authors:  Nathan O Stitziel; T Andrew Binkowski; Yan Yuan Tseng; Simon Kasif; Jie Liang
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

Review 5.  Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics.

Authors:  Lynne E Maquat
Journal:  Nat Rev Mol Cell Biol       Date:  2004-02       Impact factor: 94.444

6.  SysPTM: a systematic resource for proteomic research on post-translational modifications.

Authors:  Hong Li; Xiaobin Xing; Guohui Ding; Qingrun Li; Chuan Wang; Lu Xie; Rong Zeng; Yixue Li
Journal:  Mol Cell Proteomics       Date:  2009-04-14       Impact factor: 5.911

7.  A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1.

Authors:  Z Songyang; K P Lu; Y T Kwon; L H Tsai; O Filhol; C Cochet; D A Brickey; T R Soderling; C Bartleson; D J Graves; A J DeMaggio; M F Hoekstra; J Blenis; T Hunter; L C Cantley
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

Review 8.  How do protein kinases recognize their substrates?

Authors:  L A Pinna; M Ruzzene
Journal:  Biochim Biophys Acta       Date:  1996-12-12

9.  Identification of two serine residues essential for agonist-induced 5-HT2A receptor desensitization.

Authors:  John A Gray; Beth A Compton-Toth; Bryan L Roth
Journal:  Biochemistry       Date:  2003-09-16       Impact factor: 3.162

10.  Human Gene Mutation Database (HGMD): 2003 update.

Authors:  Peter D Stenson; Edward V Ball; Matthew Mort; Andrew D Phillips; Jacqueline A Shiel; Nick S T Thomas; Shaun Abeysinghe; Michael Krawczak; David N Cooper
Journal:  Hum Mutat       Date:  2003-06       Impact factor: 4.878

View more
  35 in total

1.  AVIA: an interactive web-server for annotation, visualization and impact analysis of genomic variations.

Authors:  Hue Vuong; Robert M Stephens; Natalia Volfovsky
Journal:  Bioinformatics       Date:  2013-11-09       Impact factor: 6.937

2.  MIMP: predicting the impact of mutations on kinase-substrate phosphorylation.

Authors:  Omar Wagih; Jüri Reimand; Gary D Bader
Journal:  Nat Methods       Date:  2015-05-04       Impact factor: 28.547

Review 3.  Methods, Tools and Current Perspectives in Proteogenomics.

Authors:  Kelly V Ruggles; Karsten Krug; Xiaojing Wang; Karl R Clauser; Jing Wang; Samuel H Payne; David Fenyö; Bing Zhang; D R Mani
Journal:  Mol Cell Proteomics       Date:  2017-04-29       Impact factor: 5.911

4.  SNPs rs10224002 in PRKAG2 may disturb gene expression and consequently affect hypertension.

Authors:  Xingbo Mo; Huan Zhang; Zhengyuan Zhou; Zhengbao Zhu; Xinfeng HuangFu; Tan Xu; Aili Wang; Zhirong Guo; Yonghong Zhang
Journal:  Mol Biol Rep       Date:  2019-01-28       Impact factor: 2.316

Review 5.  Associations among NPPA gene polymorphisms, serum ANP levels, and hypertension in the Chinese Han population.

Authors:  Huan Zhang; Xingbo Mo; Zhengyuan Zhou; Zhengbao Zhu; Xinfeng HuangFu; Tan Xu; Aili Wang; Zhirong Guo; Yonghong Zhang
Journal:  J Hum Hypertens       Date:  2019-07-24       Impact factor: 3.012

6.  Integrative analysis revealed potential causal genetic and epigenetic factors for multiple sclerosis.

Authors:  Xing-Bo Mo; Shu-Feng Lei; Qi-Yu Qian; Yu-Fan Guo; Yong-Hong Zhang; Huan Zhang
Journal:  J Neurol       Date:  2019-07-18       Impact factor: 4.849

7.  Characterization of Plasma Membrane Localization and Phosphorylation Status of Organic Anion Transporting Polypeptide (OATP) 1B1 c.521 T>C Nonsynonymous Single-Nucleotide Polymorphism.

Authors:  Alexandra Crowe; Wei Zheng; Jonathan Miller; Sonia Pahwa; Khondoker Alam; Kar-Ming Fung; Erin Rubin; Feng Yin; Kai Ding; Wei Yue
Journal:  Pharm Res       Date:  2019-05-15       Impact factor: 4.200

8.  SNP rs6265 regulates protein phosphorylation and osteoblast differentiation and influences BMD in humans.

Authors:  Fei-Yan Deng; Li-Jun Tan; Hui Shen; Yong-Jun Liu; Yao-Zhong Liu; Jian Li; Xue-Zhen Zhu; Xiang-Ding Chen; Qing Tian; Ming Zhao; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2013-12       Impact factor: 6.741

9.  Identification of IDUA and WNT16 Phosphorylation-Related Non-Synonymous Polymorphisms for Bone Mineral Density in Meta-Analyses of Genome-Wide Association Studies.

Authors:  Tianhua Niu; Ning Liu; Xun Yu; Ming Zhao; Hyung Jin Choi; Paul J Leo; Matthew A Brown; Lei Zhang; Yu-Fang Pei; Hui Shen; Hao He; Xiaoying Fu; Shan Lu; Xiang-Ding Chen; Li-Jun Tan; Tie-Lin Yang; Yan Guo; Nam H Cho; Jie Shen; Yan-Fang Guo; Geoffrey C Nicholson; Richard L Prince; John A Eisman; Graeme Jones; Philip N Sambrook; Qing Tian; Xue-Zhen Zhu; Christopher J Papasian; Emma L Duncan; André G Uitterlinden; Chan Soo Shin; Shuanglin Xiang; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2015-09-11       Impact factor: 6.741

10.  m6ASNP: a tool for annotating genetic variants by m6A function.

Authors:  Shuai Jiang; Yubin Xie; Zhihao He; Ya Zhang; Yuli Zhao; Li Chen; Yueyuan Zheng; Yanyan Miao; Zhixiang Zuo; Jian Ren
Journal:  Gigascience       Date:  2018-05-01       Impact factor: 6.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.